Startup | February 27, 2024
Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
We are achieving the target of developed India by making our young children healthy today
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Pelabresib recently met its primary endpoint of spleen volume reduction and demonstrated favorable trends in symptom improvement
Ayush is expanding beyond wellness to therapeutic wellness
EBITDA for Q3 FY24 almost tripled to reach Rs. 41.49 crore
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment of hematological malignancies and solid tumors
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America
The registered capital of the newly founded company is € 50 million
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
